Previous studies have shown significant overexpression of FOLR1 in various tumor types of epithelial origin, including lung, pancreatic, colorectal, gastric, kidney, bladder, breast, ovarian, endometrial, testicular, brain and neck cancers, compared with cognate normal tissues [34–41]. Here, FOLR1 is linked to neoplasm.